P32 Sodium Phosphate (AnazaoHealth Corporation)
Welcome to the PulseAid listing for the P32 Sodium Phosphate drug offered from AnazaoHealth Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AnazaoHealth Corporation |
NON-PROPRIETARY NAME: | P32 Sodium Phosphate |
SUBSTANCE NAME: | PHOSPHORUS P-32 |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTERSTITIAL; INTRA-ARTICULAR; INTRAPERITONEAL; INTRAPLEURAL |
DOSAGE FORM: | INJECTION, SUSPENSION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2012-06-19 |
END MARKETING DATE: | 0000-00-00 |
P32 Sodium Phosphate HUMAN PRESCRIPTION DRUG Details:
Item Description | P32 Sodium Phosphate from AnazaoHealth Corporation |
LABELER NAME: | AnazaoHealth Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mCi/mL) |
START MARKETING DATE: | 2012-06-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51808-127_5ed86373-1e27-42fc-a3b3-b198944f0dff |
PRODUCT NDC: | 51808-127 |
APPLICATION NUMBER: | |
Other PHOSPHORUS P-32 Pharmaceutical Manufacturers / Labelers: